Business Description
Femtobiomed Inc
ISIN : KR7327610002
Share Class Description:
XKRX:327610: Ordinary SharesCompare
Compare
Traded in other countries / regions
327610.Korea IPO Date
2019-07-10Description
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.87 | |||||
| Equity-to-Asset | -2.69 | |||||
| Debt-to-Equity | -0.03 | |||||
| Debt-to-EBITDA | -0.19 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -14.67 | |||||
| Beneish M-Score | 26.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 40.8 | |||||
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -28.3 | |||||
| 3-Year FCF Growth Rate | -24 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.64 | |||||
| 9-Day RSI | 52.19 | |||||
| 14-Day RSI | 48.99 | |||||
| 6-1 Month Momentum % | -26.21 | |||||
| 12-1 Month Momentum % | 3.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | |||||
| Quick Ratio | 0.16 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 398.57 | |||||
| Days Sales Outstanding | 22.6 | |||||
| Days Payable | 13.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -0.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.44 | |||||
| Operating Margin % | -1063 | |||||
| Net Margin % | -673.3 | |||||
| FCF Margin % | -731.11 | |||||
| ROA % | -61.11 | |||||
| ROIC % | -27.71 | |||||
| ROC (Joel Greenblatt) % | -204.71 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 98.16 | |||||
| EV-to-EBIT | -20.11 | |||||
| EV-to-EBITDA | -28.16 | |||||
| EV-to-Revenue | 135.39 | |||||
| EV-to-FCF | -19.41 | |||||
| Earnings Yield (Greenblatt) % | -4.97 | |||||
| FCF Yield % | -5.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Femtobiomed Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 333.954 | ||
| EPS (TTM) (â‚©) | -380 | ||
| Beta | 0 | ||
| Volatility % | 52.46 | ||
| 14-Day RSI | 48.99 | ||
| 14-Day ATR (â‚©) | 499.836918 | ||
| 20-Day SMA (â‚©) | 5373.5 | ||
| 12-1 Month Momentum % | 3.47 | ||
| 52-Week Range (â‚©) | 4510 - 10870 | ||
| Shares Outstanding (Mil) | 8.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Femtobiomed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Femtobiomed Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Femtobiomed Inc Frequently Asked Questions
What is Femtobiomed Inc(XKRX:327610)'s stock price today?
The current price of XKRX:327610 is â‚©5520.00. The 52 week high of XKRX:327610 is â‚©10870.00 and 52 week low is â‚©4510.00.
When is next earnings date of Femtobiomed Inc(XKRX:327610)?
The next earnings date of Femtobiomed Inc(XKRX:327610) is .
Does Femtobiomed Inc(XKRX:327610) pay dividends? If so, how much?
Femtobiomed Inc(XKRX:327610) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers